Noon – 1:00 pm EST
Please click here to view the full presentation.
McDermott Will & Emery is pleased to present another complimentary webcast in its regular “Life Sciences: Understanding Opportunities and Challenges for Improved Business Results” series. The recent decision by the U.S. Court of Appeals for the Third Circuit in striking down a settlement which involved a so-called "reverse payment" has injected new life into the Federal Trade Commission’s (FTC) campaign against these types of settlements. Although the state of the law may be in question as a result of this decision, both branded and generic companies need to make critically important business and legal decisions now about whether to litigate or settle -- and how to settle -- these "bet the company" types of cases.
Our distinguished panel will dissect the court's opinion and put the decision in the context of the existing jurisprudence in this area. We will examine the prospects for review of the decision by the Supreme Court of the United States, and forecast the Court's likely analysis of the issues should it choose to review the case. During the webcast, we will also address the implications of the current state of affairs for intellectual property litigation and business strategies in general.
M. Miller Baker, Partner
Jeffrey Brennan, Partner, Former Head of the FTC’s Health Care Division
William Gaede, Partner
Glenn Engelmann, Senior Counsel, Former AstraZeneca U.S. General Counsel
For more information, please contact McDermott Events.
CLE credit for the live presentation of this program is pending in the following states: California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states. Please be advised that CLE credit will not be approved for on demand/recorded viewings of this program in the states listed above. Attendees seeking credit in other states should consult their state CLE accrediting agency to determine whether self-study credit can be earned for on demand/recorded viewing of this program.